Larisa Belyanskaya
Lachen, SZ, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Characterization of a factor VIII/immunoglobulin heavy chain μ double-knockout mouse model of hemophilia A for long-term exposure to factor VIII proteins.
Journal: Research and practice in thrombosis and haemostasis
Published: July 27, 2025
Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect study.
Journal: European journal of haematology
Published: March 17, 2023
Immune Tolerance Induction (ITI) with a pdFVIII/VWF Concentrate (octanate) in 100 Patients in the Observational ITI (ObsITI) Study.
Journal: TH open : companion journal to thrombosis and haemostasis
Published: August 20, 2021
Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study.
Journal: Thrombosis and haemostasis
Published: February 13, 2021
Efficacy and safety of simoctocog alfa (Nuwiq®) in patients with severe hemophilia A: a review of clinical trial data from the GENA program.
Journal: Therapeutic advances in hematology
Published: October 10, 2018
Estimation of Nuwiq® (simoctocog alfa) activity using one-stage and chromogenic assays-Results from an international comparative field study.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: September 10, 2018
Low incidence of factor VIII inhibitors in previously untreated patients with severe haemophilia A treated with octanate® : Final report from a prospective study.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: November 12, 2017
Immunogenicity, efficacy and safety of Nuwiq® (human-cl rhFVIII) in previously untreated patients with severe haemophilia A-Interim results from the NuProtect Study.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: July 05, 2017
PK-guided personalized prophylaxis with Nuwiq® (human-cl rhFVIII) in adults with severe haemophilia A.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: March 16, 2017
First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: June 14, 2015
Development, upscaling and validation of the purification process for human-cl rhFVIII (Nuwiq®), a new generation recombinant factor VIII produced in a human cell-line.
Journal: Protein expression and purification
Published: May 28, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026